Among people eligible for treatment, 33.1% (95% CI, 31.4-34.8), 28.1% (95% CI, 26.4-29.8) and 26.2% (95% CI, 24.6-27.9) met the exclusion criteria for tirzepatide, liraglutide and semaglutide, respectively
If you are struggling with severe post-injection diarrhea, discussing dose splitting with a healthcare provider may be worthwhile
kind of like seeing the first few pounds drop on the scale after switching to iced coffee instead of a Frappuccino
Image Credit: Nemes Laszlo / Shutterstock In a recent study published in the Journal of the American Heart Association , researchers emulated a target trial to assess the association between glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment and the risk of thromboembolic and cardiovascular events in adults with obesity and comorbid autoimmune disease (AID)
Notably, semaglutide was not associated with higher risks for severe gastrointestinal disorders, pancreatitis, psychiatric disorders or kidney injury